This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cutaneous Radiation Injury Treatment Market

Market Insights on Cutaneous Radiation Injury Treatment covering sales outlook, demand forecast & up-to-date key trends

Cutaneous Radiation Injury Treatment Market by Exposure Type, Stage, Route of Administration, Drug Type, Distribution Channel & Region - Forecast 2022-2032

Cutaneous Radiation Injury Treatment Market Snapshot

The global cutaneous radiation injury treatment market size is expected to be valued at US$ 4.1 Billion in 2022. It is likely to exhibit growth at a CAGR of 2.9% in the forecast period from 2022 to 2032. Increasing cases of cancer leading to the rising usage of radiation therapy are anticipated to bolster growth in future. As per FMI, sales of cutaneous radiation injury treatment options are set to reach US$ 8.6 Billion in 2032.

Report Attribute

Details

Cutaneous Radiation Injury Treatment Market Estimated Base Year Value (2021)

US$ 3.7 Billion

Cutaneous Radiation Injury Treatment Market Expected Market Value (2022)

US$ 4.1 Billion

Cutaneous Radiation Injury Treatment Market Anticipated Forecast Value (2032)

US$ 8.6 Billion

Cutaneous Radiation Injury Treatment Market Projected Growth Rate (2022-2032)

2.9% CAGR

Cutaneous radiation injuries occur on a gross, cellular, and functional level. These are considered to be a significant modality in the management of cancer, along with chemotherapy and surgery.

Some of the most common side effects of cutaneous radiation injuries are swelling caused by a buildup of fluid called edema, itchiness, skin redness, and tingling.

Demand for cutaneous radiation injury treatment solutions is likely to surge with the rising prevalence of acute skin reactions that mainly range from confluent moist desquamation to mild. The introduction of cutting-edge technologies by key players is another major factor that is set to create new growth opportunities in the global market.

Cutaneous radiation injury has nowadays become a serious concern with the rising cancer morbidity and wide usage of radiation for cancer therapy. Research and development activities aiming to discover new treatment options for these injuries are anticipated to augur well for the global market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Is the Prevalence of Cancer Pushing the Cutaneous Radiation Injury Treatment Market Growth?

As the prevalence of cancer is increasing worldwide, the need for radiation therapy is also surging at a rapid pace. It is leading to changes in the tumors and tissues where radiation therapy is given, thereby boosting the cutaneous radiation injury treatment market growth.

Increasing cases of cardiovascular surgeries and rising prevalence of cancer among the ever-increasing population are some of the other factors that are expected to bolster the market. According to the World Health Organization (WHO), cancer accounted for approximately 10 million deaths across the globe in 2020. The most common types of cancer are rectum, lung, prostate, colon, and breast cancers. This trend is estimated to continue in future years, thereby pushing the market.

Which Factors Are Hampering the Cutaneous Radiation Injury Treatment Market Growth?

In underdeveloped countries, cancer and cutaneous radiation injury treatment are an expensive process. Thus, not many people can afford these facilities. Also, regulatory bodies in these countries lack the fund required to install certain healthcare devices in hospitals for advanced care options. These factors may hamper the sales of cutaneous radiation injury treatment solutions in the evaluation period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the North America Cutaneous Radiation Injury Treatment Market Faring?

Presence of a well-developed healthcare infrastructure is expected to propel the North America cutaneous radiation injury treatment market share in the assessment period. Also, favorable reimbursement policies available in the U.S. and Canada are likely to contribute to this growth.

High demand for radiation therapy owing to the rising cases of cancer is another crucial factor that is projected to aid the regional market. The American Cancer Society, for instance, stated that in 2021, there were an estimated 1.9 million new cases of cancer in the U.S. and about 608,570 deaths. These numbers are expected to surge at a fast pace in the upcoming years, thereby propelling the North America market.

Why is the Asia Pacific Cutaneous Radiation Injury Treatment Market Growing Steadily?

Asia Pacific is projected to remain in the second position, followed by North America. Increasing awareness programs conducted by government and private agencies in India and China to educate the masses regarding the available treatment options for cancer are likely to push the demand for cutaneous radiation injury treatment options.

Moreover, the availability of relatively low cost treatment options and high patient pool in these countries are anticipated to bode well for the regional market. The ongoing development of new drugs and increasing R&D activities conducted by key companies in this region are also expected to aid growth.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the prominent companies operating in the global cutaneous radiation injury treatment market include AstraZeneca, Merck & Co., Teva Pharmaceutical, Novartis AG, Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche Ltd., Johnson and Johnson, and Amgen among others.

The majority of the leading players in the market are increasingly focusing on joining hands with cancer research institutions to help them find new treatment options for cutaneous radiation injuries.

A few other key players are engaging in joint ventures, collaborations, and mergers & acquisition activities with start-up firms and international companies to expand their product portfolios and generate high shares in the global market.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 2.9% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Exposure Type
  • Stage
  • Route of Administration
  • Drug Type
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • AstraZeneca
  • Merck & Co.
  • Teva Pharmaceutical
  • Novartis AG
  • Eli Lilly and Company
  • Pfizer Inc.
  • Hoffmann-La Roche Ltd.
  • Johnson and Johnson
  • Amgen

Customization

Available Upon Request

Key Segments Profiled in the Cutaneous Radiation Injury Treatment Industry Survey

By Exposure Type:

  • Contamination
  • Irradiation

By Stage:

  • Prodromal Stage
  • Latent Stage
  • Manifest Illness Stage
  • Third Wave of Erythema

By Route of Administration:

  • Oral
  • Topical

By Drug Type:

  • Nonsteroidal anti-inflammatory drugs
  • Antihistamine
  • Antibiotics
  • Corticosteroids
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Mail Order Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global cutaneous radiation injury treatment market is likely to reach US$ 8.6 Billion in 2032.

North America is set to dominate the cutaneous radiation injury treatment market in the forecast period.

AstraZeneca, Merck & Co., Teva Pharmaceutical, Novartis AG, Eli Lilly and Company, Pfizer Inc., and Hoffmann-La Roche Ltd. are some of the leading companies in the cutaneous radiation injury treatment market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Acute Kidney Injury Treatment Market

Published : March 2022

Healthcare

White Matter Injury Treatment Market

Published : December 2018

Healthcare

Winter Sports Injury Treatment Market

Published : January 2016

Healthcare

Kids Sports Injury Treatment Market

Published : January 2016

Google translate

Cutaneous Radiation Injury Treatment Market